Document ID: chunk:federal_register_of_legislation:F2024L00497:reg:4
Version: federal_register_of_legislation:F2024L00497
Segment Type: reg
Provision Reference: reg 4
Character Range: 1848–2427

4  Schedules
  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule — Amendments

National Health (Pharmaceutical Benefits Scheme–Exempt items – Section 84AH) Determination 2017 (PB 81 of 2017)

  [1]  In the Schedule, after the entry for Ondansetron Syrup, 4 mg (as hydrochloride dihydrate) per 5 mL, 50mL
             Insert:

Oxybutynin  Transdermal patches 36 mg, 8  Transdermal